The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer

by Jia Li Low, Robert J. Walsh, Yvonne Ang, Gloria Chan, Ross A. Soo
Published 2019-08-01

Advances in the management of non-small-cell lung cancer harbouring exon 20 insertion mutations

by Jia Li Low, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho, Ross A Soo
Published 2023-01-01

Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank)

by Jia Li Low, Yiqing Huang, Kenneth Sooi, Zhi Yao Chan, Wei Peng Yong, Wei Peng Yong, Soo Chin Lee, Soo Chin Lee, Soo Chin Lee, Boon Cher Goh, Boon Cher Goh, Boon Cher Goh
Published 2022-11-01

Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors—Navigating the Radiologic Potpourri

by Alvin Wong, Balamurugan Vellayappan, Lenith Cheng, Joseph J. Zhao, Vaishnavi Muthu, Yugarajah Asokumaran, Jia-Li Low, Matilda Lee, Yi-Qing Huang, Nesaretnam Barr Kumarakulasinghe, Natalie Ngoi, Cheng-Nang Leong, Wynne Chua, Yee-Liang Thian
Published 2021-04-01

Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer

by Yiqing Huang, Joseph J. Zhao, Yu Yang Soon, Alvin Wong, Folefac Aminkeng, Yvonne Ang, Yugarajah Asokumaran, Jia Li Low, Matilda Lee, Joan R. E. Choo, Gloria Chan, Adrian Kee, Sen Hee Tay, Boon Cher Goh, Ross A. Soo
Published 2022-11-01

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

by Jia Li Low, Elaine Lim, Lavina Bharwani, Andrea Wong, Karmen Wong, Samuel Ow, Siew Eng Lim, Matilda Lee, Joan Choo, Joline Lim, Gloria Chan, Robert John Walsh, Vaishnavi Muthu, Natalie Ngoi, Wanqin Chong, Sing Huang Tan, Soo Chin Lee
Published 2022-12-01